col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


122 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Cellular and Molecular Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―26 COVID-19 vaccines and beyond Yiyuan Liu, Danying Li, Jiahuai Han
2 [GO] 2024―Jan―18 SARS-CoV-2 immunity Antonio Bertoletti
3 [GO] 2024―Jan―18 SARS-CoV-2 immunity in animal models Zhao Chen, Yaochang Yuan, Qingtao Hu, Airu Zhu, Fenghua Chen, Shu Li, et al. (+10)
4 [GO] 2024―Jan―15 Silent battles: immune responses in asymptomatic SARS-CoV-2 infection Nina Le Bert, Taraz Samandari
5 [GO] 2023―Dec―25 Olfactory immune response to SARS-CoV-2 Sebastian A. Wellford, E. Ashley Moseman
6 [GO] 2023―Nov―20 SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks” Benjamin L. Sievers, Mark T. K. Cheng, Kata Csiba, Bo Meng, Ravindra K. Gupta
7 [GO] 2023―Nov―14 The interplay of drug therapeutics and immune responses to SARS-CoV-2 Valeria Fumagalli, Matteo Iannacone
8 [GO] 2023―Nov―10 B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity Dennis Lapuente, Thomas H. Winkler, Matthias Tenbusch
9 [GO] 2023―Oct―11 The immune response to SARS-CoV-2 in people with HIV Maxine A. Höft, Wendy A. Burgers, Catherine Riou
10 [GO] 2023―Sep―05 Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy Qi Chen, Adeline Chia, Shou Kit Hang, Amy Lim, Wee Kun Koh, Yanchun Peng, et al. (+13)
11 [GO] 2023―May―30 Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation O. García-Nicolás, A. Godel, G. Zimmer, A. Summerfield
12 [GO] 2023―May―08 Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage Inga Nehlmeier, Amy Kempf, Prerna Arora, Anne Cossmann, Alexandra Dopfer-Jablonka, Metodi V. Stankov, et al. (+5)
13 [GO] 2023―Apr―25 Author Correction: SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy Xingyu Li, Peili Hou, Wenqing Ma, Xuefeng Wang, Hongmei Wang, Zhangping Yu, et al. (+11)
14 [GO] 2023―Mar―27 SARS-CoV-2 peptides/epitopes for specific and sensitive diagnosis He-Wei Jiang, Yang Li, Sheng-Ce Tao
15 [GO] 2023―Mar―03 Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5 Markus Hoffmann, Prerna Arora, Inga Nehlmeier, Amy Kempf, Anne Cossmann, Sebastian R. Schulz, et al. (+5)
16 [GO] 2023―Mar―02 A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19 Lin Xia, Lun-zhi Yuan, Ya-hong Hu, Jun-yi Liu, Guo-sheng Hu, Ruo-yao Qi, et al. (+13)
17 [GO] 2022―Oct―18 Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters Lunzhi Yuan, Huachen Zhu, Peiwen Chen, Ming Zhou, Jian Ma, Xuan Liu, et al. (+13)
18 [GO] 2022―Oct―12 Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2 Qiaoli Peng, Runhong Zhou, Na Liu, Hui Wang, Haoran Xu, Meiqing Zhao, et al. (+5)
19 [GO] 2022―Oct―11 The compartmentalized upper respiratory mucosa needs time to rally a sufficient immune force for SARS-CoV-2 clearance Xiaowen Zheng, Xiaoping Tang, Feng Li
20 [GO] 2022―Oct―11 A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern Jingyi Yang, Mei-Qin Liu, Lin Liu, Xian Li, Mengxin Xu, Haofeng Lin, et al. (+9)
21 [GO] 2022―Sep―01 Rethinking sepsis after a two-year battle with COVID-19 Yingying Zhang, Jiahuai Han
22 [GO] 2022―Aug―30 Correction: COVID-19 and flu: conserved or specific immune signature? Christophe Paget, François Trottein
23 [GO] 2022―Aug―30 Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months Pai Peng, Jie Hu, Hai-jun Deng, Bei-zhong Liu, Liang Fang, Kai Wang, et al. (+2)
24 [GO] 2022―Aug―30 Correction: The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity Jonas Buttenschön, Jochen Mattner
25 [GO] 2022―Jul―12 Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells Daniel Perez-Zsolt, Jordana Muñoz-Basagoiti, Jordi Rodon, Marc Elosua-Bayes, Dàlia Raïch-Regué, Cristina Risco, et al. (+24)
26 [GO] 2022―Jun―24 Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants Yang Yang, Lanying Du
27 [GO] 2022―Jun―23 SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1 Shilei Zhang, Jingfeng Wang, Lulan Wang, Saba Aliyari, Genhong Cheng
28 [GO] 2022―Jun―08 Jigsaw puzzle of SARS-CoV-2 RBD evolution and immune escape Chunyan Yi, Xiaoyu Sun, Zhiyang Ling, Bing Sun
29 [GO] 2022―May―17 Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Sebastian Schulz, Anne Cossmann, et al. (+6)
30 [GO] 2022―Mar―29 A SARS-CoV-2 antibody retains potent neutralization against Omicron by targeting conserved RBM residues Chunyan Yi, Zhiyang Ling, Xiao Lu, Yadong Fu, Zhuo Yang, Sonam Wangmo, et al. (+7)
31 [GO] 2022―Mar―29 Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals Zi-Wei Ye, Chon Phin Ong, Kaiming Tang, Yilan Fan, Cuiting Luo, Runhong Zhou, et al. (+13)
32 [GO] 2022―Mar―25 Why are children less affected than adults by severe acute respiratory syndrome coronavirus 2 infection? Chang Kyung Kang, Hyun Mu Shin, Wan Beom Park, Hang-Rae Kim
33 [GO] 2022―Mar―10 Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells Weiqi Hong, Jingyun Yang, Jun Zou, Zhenfei Bi, Cai He, Hong Lei, et al. (+51)
34 [GO] 2022―Jan―24 Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant Wei Zhang, Linfen Huang, Gang Ye, Qibin Geng, Nwando Ikeogu, Morgan Harris, et al. (+5)
35 [GO] 2022―Jan―18 T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant Seong Jin Choi, Dong-Uk Kim, Ji Yun Noh, Sangwoo Kim, Su-Hyung Park, Hye Won Jeong, Eui-Cheol Shin
36 [GO] 2022―Jan―13 NK cell dysfunction in patients with COVID-19 Jiacheng Bi
37 [GO] 2022―Jan―11 Increased immune escape of the new SARS-CoV-2 variant of concern Omicron Jie Hu, Pai Peng, Xiaoxia Cao, Kang Wu, Juan Chen, Kai Wang, et al. (+2)
38 [GO] 2022―Jan―07 Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2 Jonas Buttenschön, Stefan Vogt, Jochen Mattner
39 [GO] 2022―Jan―05 Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane Fontenot, Pyone Pyone Aye, et al. (+17)
40 [GO] 2022―Jan―05 Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters Lunzhi Yuan, Ming Zhou, Jian Ma, Xuan Liu, Peiwen Chen, Huachen Zhu, et al. (+4)
41 [GO] 2022―Jan―04 SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages Zhenfeng Wang, Jiadi Lv, Pin Yu, Yajin Qu, Yabo Zhou, Li Zhou, et al. (+10)
42 [GO] 2021―Nov―29 SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy Xingyu Li, Peili Hou, Wenqing Ma, Xuefeng Wang, Hongmei Wang, Zhangping Yu, et al. (+11)
43 [GO] 2021―Nov―15 Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection Tiandan Xiang, Boyun Liang, Hua Wang, Xufeng Quan, Shengsong He, Helong Zhou, et al. (+4)
44 [GO] 2021―Nov―15 SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells Daniel Perez-Zsolt, Jordana Muñoz-Basagoiti, Jordi Rodon, Marc Elosua-Bayes, Dàlia Raïch-Regué, Cristina Risco, et al. (+24)
45 [GO] 2021―Nov―02 Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice Xiaoxiao Jin, Yan Ding, Shihui Sun, Xinyi Wang, Zining Zhou, Xiaotao Liu, et al. (+12)
46 [GO] 2021―Oct―25 The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency Prerna Arora, Cheila Rocha, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S. Winkler, et al. (+8)
47 [GO] 2021―Oct―13 A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development Tuofan Li, Qiuqi Kan, Jinying Ge, Zhimin Wan, Mengqi Yuan, Yao Huang, et al. (+9)
48 [GO] 2021―Oct―13 Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects Jiaxin Zheng, Yingying Deng, Zhenyu Zhao, Binli Mao, Mengji Lu, Yong Lin, Ailong Huang
49 [GO] 2021―Oct―11 Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains Ting Pan, Zhongwei Hu, Fengyu Hu, Yiwen Zhang, Bingfeng Liu, Changwen Ke, et al. (+4)
50 [GO] 2021―Sep―16 T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals Stanley C. Jordan, Bong-Ha Shin, Terry-Ann M. Gadsden, Maggie Chu, Anna Petrosyan, Catherine N. Le, et al. (+12)
51 [GO] 2021―Sep―08 Neutralizing antibodies for the prevention and treatment of COVID-19 Lanying Du, Yang Yang, Xiujuan Zhang
52 [GO] 2021―Sep―06 Publisher Correction: Epitopes for a 2019-nCoV vaccine Guglielmo Lucchese
53 [GO] 2021―Sep―01 Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection Xin Wang, Gang Xu, Xiaoju Liu, Yang Liu, Shuye Zhang, Zheng Zhang
54 [GO] 2021―Sep―01 SARS-CoV-2-specific T cells in infection and vaccination Antonio Bertoletti, Nina Le Bert, Martin Qui, Anthony T. Tan
55 [GO] 2021―Aug―31 FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes Gema Frühbeck, Victoria Catalán, Víctor Valentí, Rafael Moncada, Javier Gómez-Ambrosi, Sara Becerril, et al. (+4)
56 [GO] 2021―Aug―23 Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination Swantje I. Hammerschmidt, Berislav Bosnjak, Günter Bernhardt, Michaela Friedrichsen, Inga Ravens, Alexandra Dopfer-Jablonka, et al. (+4)
57 [GO] 2021―Aug―19 Activation or exhaustion of CD8+ T cells in patients with COVID-19 Min-Seok Rha, Eui-Cheol Shin
58 [GO] 2021―Jul―28 Increase in serum levels of phosphatidylserine-specific phospholipase A1 in COVID-19 patients Takuya Shimura, Makoto Kurano, Koh Okamoto, Daisuke Jubishi, Kuniyuki Kano, Koji Igarashi, et al. (+4)
59 [GO] 2021―Jul―21 Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection Alberto Pérez-Gómez, Joana Vitallé, Carmen Gasca-Capote, Alicia Gutierrez-Valencia, María Trujillo-Rodriguez, Ana Serna-Gallego, et al. (+112)
60 [GO] 2021―Jul―19 Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19 Xiuying Mu, Kai Liu, Huajie Li, Fu-Sheng Wang, Ruonan Xu
61 [GO] 2021―Jul―19 Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles Xiantao Zhang, Yaochang Yuan, Bolin Wu, Xuemei Wang, Yingtong Lin, Yuewen Luo, et al. (+7)
62 [GO] 2021―Jul―15 SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients Yao Deng, Yu Li, Ren Yang, Wenjie Tan
63 [GO] 2021―Jun―09 Mucins produced by type II pneumocyte: culprits in SARS-CoV-2 pathogenesis Bo Huang
64 [GO] 2021―Jun―07 Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection Hao Wang, Yu Yuan, Mingzhong Xiao, Li Chen, Youyun Zhao, Pinpin Long, et al. (+21)
65 [GO] 2021―May―31 Cross-reactive antibody immunity against SARS-CoV-2 in children and adults Elizabeth Fraley, Cas LeMaster, Dithi Banerjee, Santosh Khanal, Rangaraj Selvarangan, Todd Bradley
66 [GO] 2021―May―31 Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 Huiqing Xiu, Jiali Gong, Tiancha Huang, Yanmei Peng, Songjie Bai, Guirun Xiong, et al. (+4)
67 [GO] 2021―May―10 IL-33 in COVID-19: friend or foe? Yuejin Liang, Yiyue Ge, Jiaren Sun
68 [GO] 2021―May―06 Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein-ACE2 interaction MengYa Yuan, YaoYing Wan, Cui Liu, Yue Li, ZhaoYuan Liu, ChangDong Lin, JianFeng Chen
69 [GO] 2021―Apr―01 ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques Jiadi Lv, Pin Yu, Zhenfeng Wang, Wei Deng, Linlin Bao, Jiangning Liu, et al. (+12)
70 [GO] 2021―Mar―19 Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm Jinghe Zhang, Haibo Wu, XiaoHong Yao, Dingyu Zhang, Yonggang Zhou, Binqing Fu, et al. (+9)
71 [GO] 2021―Mar―17 Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice Shihui Sun, Lei He, Zhongpeng Zhao, Hongjing Gu, Xin Fang, Tiecheng Wang, et al. (+22)
72 [GO] 2021―Mar―04 Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution Huan Qi, Ming-liang Ma, He-wei Jiang, Jian-ya Ling, Ling-yun Chen, Hai-nan Zhang, et al. (+13)
73 [GO] 2021―Feb―26 Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients Penghui Yang, Yingze Zhao, Jie Li, Chuanyu Liu, Linnan Zhu, Jie Zhang, et al. (+22)
74 [GO] 2021―Feb―26 SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation Wenjing Wang, Zhuo Zhou, Xia Xiao, Zhongqin Tian, Xiaojing Dong, Conghui Wang, et al. (+5)
75 [GO] 2021―Feb―25 Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies Jie Hu, Pai Peng, Kai Wang, Liang Fang, Fei-yang Luo, Ai-shun Jin, et al. (+3)
76 [GO] 2021―Feb―13 Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, et al. (+4)
77 [GO] 2021―Feb―13 Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice Wenjun Wang, Baoying Huang, Yanping Zhu, Wenjie Tan, Mingzhao Zhu
78 [GO] 2021―Jan―22 Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients Yang Li, Dan-yun Lai, Qing Lei, Zhao-wei Xu, Feng Wang, Hongyan Hou, et al. (+27)
79 [GO] 2021―Jan―20 Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response Zengguo Cao, Hongjie Xia, Ricardo Rajsbaum, Xianzhu Xia, Hualei Wang, Pei-Yong Shi
80 [GO] 2021―Jan―14 SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19 Victor M. Arce, Jose A. Costoya
81 [GO] 2021―Jan―11 COVID-19 and flu: conserved or specific immune signature? Christophe Paget, François Trottein
82 [GO] 2021―Jan―08 Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months Pai Peng, Jie Hu, Hai-jun Deng, Bei-zhong Liu, Liang Fang, Kai Wang, et al. (+2)
83 [GO] 2021―Jan―08 The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity Jonas Buttenschön, Jochen Mattner
84 [GO] 2021―Jan―06 A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity Vincent Legros, Solène Denolly, Manon Vogrig, Bertrand Boson, Eglantine Siret, Josselin Rigaill, et al. (+16)
85 [GO] 2020―Dec―14 Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients Xixiang Ma, Chuhuai Guan, Rong Chen, Yunyun Wang, Shenglei Feng, Rongshuai Wang, et al. (+8)
86 [GO] 2020―Dec―14 Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment Alejandra Gomez-Cadena, Laurie Spehner, Marie Kroemer, Myriam Ben Khelil, Kevin Bouiller, Grégory Verdeil, et al. (+4)
87 [GO] 2020―Nov―26 New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein Junzhi Wang
88 [GO] 2020―Nov―02 Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, Anne Katrin Cordes, Wolfram Puppe, Günter Bernhardt, et al. (+16)
89 [GO] 2020―Oct―27 SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response Yu-Zhi Fu, Su-Yun Wang, Zhou-Qin Zheng, Wei-Wei Li, Zhi-Sheng Xu, Yan-Yi Wang
90 [GO] 2020―Oct―15 Unique immunological profile in patients with COVID-19 Stefania Varchetta, Dalila Mele, Barbara Oliviero, Stefania Mantovani, Serena Ludovisi, Antonella Cerino, et al. (+8)
91 [GO] 2020―Oct―09 A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract Fengyu Hu, Fengjuan Chen, Zhihua Ou, Qinghong Fan, Xinghua Tan, Yaping Wang, et al. (+16)
92 [GO] 2020―Oct―02 Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients Meijuan Zheng, Yong Gao, Siyu Liu, Dandan Sun, Fan Yang, Lu Zong, et al. (+4)
93 [GO] 2020―Sep―17 Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies Bingfeng Liu, Yaling Shi, Wanying Zhang, Rong Li, Zhangping He, Xiaofan Yang, et al. (+13)
94 [GO] 2020―Sep―11 Low glycosylated ferritin is a sensitive biomarker of severe COVID-19 Maxime Fauter, Sébastien Viel, Sabine Zaepfel, Pierre Pradat, Julie Fiscus, Marine Villard, et al. (+5)
95 [GO] 2020―Sep―11 Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019 Lan Huang, Xuan Zhao, Yu Qi, Hong Li, Guanchao Ye, Yafei Liu, et al. (+2)
96 [GO] 2020―Sep―07 Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients Yang Li, Dan-yun Lai, Hai-nan Zhang, He-wei Jiang, Xiaolong Tian, Ming-liang Ma, et al. (+11)
97 [GO] 2020―Sep―03 Expansion of atypical memory B cells is a prominent feature of COVID-19 Barbara Oliviero, Stefania Varchetta, Dalila Mele, Stefania Mantovani, Antonella Cerino, Cesare G. Perotti, et al. (+2)
98 [GO] 2020―Jul―29 Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient Guillaume Monneret, Donatien de Marignan, Rémy Coudereau, Céline Bernet, Florence Ader, Emilie Frobert, et al. (+4)
99 [GO] 2020―Jul―29 SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 He-wei Jiang, Hai-nan Zhang, Qing-feng Meng, Jia Xie, Yang Li, Hong Chen, et al. (+7)
100 [GO] 2020―Jul―10 Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion Xinling Wang, Wei Xu, Gaowei Hu, Shuai Xia, Zhiping Sun, Zezhong Liu, et al. (+4)
101 [GO] 2020―Jul―03 Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients Liting Chen, Xiaolu Long, Qian Xu, Jiaqi Tan, Gaoxiang Wang, Yang Cao, et al. (+19)
102 [GO] 2020―Jul―01 Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 Olivier Demaria, Julien Carvelli, Luciana Batista, Marie-Laure Thibult, Ariane Morel, Pascale André, et al. (+3)
103 [GO] 2020―Jun―25 Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients Yaguang Zhang, Xiaojing Wang, Xuezhen Li, Dong Xi, Ruizhi Mao, Xiaohui Wu, et al. (+9)
104 [GO] 2020―Jun―18 The ORF3a protein of SARS-CoV-2 induces apoptosis in cells Yujie Ren, Ting Shu, Di Wu, Jingfang Mu, Chong Wang, Muhan Huang, et al. (+5)
105 [GO] 2020―Jun―15 Systemically comparing host immunity between survived and deceased COVID-19 patients Feng Wang, Hongyan Hou, Yin Yao, Shiji Wu, Min Huang, Xiao Ran, et al. (+3)
106 [GO] 2020―May―28 Serum IgA, IgM, and IgG responses in COVID-19 Huan Ma, Weihong Zeng, Hongliang He, Dan Zhao, Dehua Jiang, Peigen Zhou, et al. (+4)
107 [GO] 2020―May―28 More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells Ger Rijkers, Trees Vervenne, Pieter van der Pol
108 [GO] 2020―May―15 Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, et al. (+9)
109 [GO] 2020―May―12 Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? Chao Zhang, Fu-Sheng Wang, Jean-Sébastien Silvestre, Fernando Arenzana-Seisdedos, Hong Tang
110 [GO] 2020―May―07 NKG2A and COVID-19: another brick in the wall Luca Antonioli, Matteo Fornai, Carolina Pellegrini, Corrado Blandizzi
111 [GO] 2020―May―07 Protective humoral immunity in SARS-CoV-2 infected pediatric patients Yaguang Zhang, Jin Xu, Ran Jia, Chunyan Yi, Wangpeng Gu, Pengcheng Liu, et al. (+14)
112 [GO] 2020―Apr―28 High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients Wenjing Wang, Bin Su, Lijun Pang, Luxin Qiao, Yingmei Feng, Yabo Ouyang, et al. (+7)
113 [GO] 2020―Apr―20 Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor Xiangyu Chen, Ren Li, Zhiwei Pan, Chunfang Qian, Yang Yang, Renrong You, et al. (+18)
114 [GO] 2020―Apr―07 SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion Xinling Wang, Wei Xu, Gaowei Hu, Shuai Xia, Zhiping Sun, Zezhong Liu, et al. (+4)
115 [GO] 2020―Mar―31 COVID-19: a new challenge for human beings Penghui Yang, Xiliang Wang
116 [GO] 2020―Mar―19 Functional exhaustion of antiviral lymphocytes in COVID-19 patients Meijuan Zheng, Yong Gao, Gang Wang, Guobin Song, Siyu Liu, Dandan Sun, et al. (+2)
117 [GO] 2020―Mar―19 Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, et al. (+2)
118 [GO] 2020―Mar―17 Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients Hong-Yi Zheng, Mi Zhang, Cui-Xian Yang, Nian Zhang, Xi-Cheng Wang, Xin-Ping Yang, et al. (+2)
119 [GO] 2020―Mar―04 Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV Ming Zheng, Lun Song
120 [GO] 2020―Feb―24 Epitopes for a 2019-nCoV vaccine Guglielmo Lucchese
121 [GO] 2020―Feb―11 Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein Shuai Xia, Yun Zhu, Meiqin Liu, Qiaoshuai Lan, Wei Xu, Yanling Wu, et al. (+5)
122 [GO] 2020―Feb―05 A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome Shibo Jiang, Shuai Xia, Tianlei Ying, Lu Lu
 [1] 

122 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.012 sec